Biote (BTMD) Gains from Sales and Divestitures (2022 - 2026)

Biote's Gains from Sales and Divestitures history runs 5 years deep, the most recent figure standing at $7376.0 for Q1 2026.

• In Q1 2026, Gains from Sales and Divestitures changed N/A year-over-year to $7376.0; the TTM figure through Mar 2026 stood at $7376.0 (changed N/A YoY), while the FY2025 annual figure was $24039.0, down 94.6% from the prior year.
• Gains from Sales and Divestitures was $7376.0 for Q1 2026 at Biote, down from $24039.0 in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of $2.1 million in Q4 2022 to a low of $7376.0 in Q1 2026.
• Historically, Gains from Sales and Divestitures has averaged $554573.9 across 5 years, with a median of $435495.5 in 2023.
• The sharpest annual moves came in 2023 and 2025: Gains from Sales and Divestitures advanced 25.68% in 2023, then slumped 94.6% in 2025.
• A 5-year view of Gains from Sales and Divestitures shows it stood at $2.1 million in 2022, then plunged by 39.11% to $1.3 million in 2023, then tumbled by 64.43% to $444783.0 in 2024, then plunged by 94.6% to $24039.0 in 2025, then plunged by 69.32% to $7376.0 in 2026.
• The last three Gains from Sales and Divestitures figures came in at $7376.0 (Q1 2026), $24039.0 (Q4 2025), and $24039.0 (Q3 2025), per Business Quant data.